EMA Releases Statement on Brexit
13 July 2016
The European Medicines Agency (EMA) says the future location of the agency will be determined by common agreement between representatives of the Member States, according to a July 6, 2016 statement. Until then, EMA says it will be conducting business as usual, and the outcome of the June 23 referendum will not affect the agency’s operations.
Survey Results Explores Biopharma Risk Model
13 July 2016
Biopharmaceutical executives are optimistic about their abilities to launch new drugs, in the next five years, but nearly one-third voiced concerns about potential regulatory roadblocks, according to a survey sponsored by MilliporeSigma and conducted by the Economist Intelligence Unit. The survey results were released at the 2016 BIO International Convention in San Francisco in early June 2016.
Cancer data collections efforts grow in China
13 July 2016
Two examples of efforts to expand data insights into cancer in China show the potential scope of a national "big data plan" for healthcare for both domestic and foreign players outlined in June--a policy that seeks to standardize patient and clinical data on a massive scale by the end of the decade.
Ferring announces data from its Phase III ESTHER trials
12 July 2016
Ferring Pharmaceuticals have announced data from their ESTHER trials at the Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).
International collaboration to create new cancer models to accelerate research
12 July 2016
An international project to develop a large, globally accessible bank of new cancer cell culture models for the research community launched today. The National Cancer Institute (NCI), part of the National Institutes of Health; Cancer Research UK, London; the Wellcome Trust Sanger Institute, Cambridge, England; and the foundation Hubrecht Organoid Technology, Utrecht, Netherlands, are joining forces to develop the Human Cancer Models Initiative (HCMI), which will bring together expertise from around the world to make about 1,000 cancer cell models.
Diabetes sales rocket toward $60B
12 July 2016
Two sides of one coin will keep diabetes drug sales growing--big time--through 2025. The disease is growing fast around the world, and treatment arbiters advise a more aggressive approach to blood-sugar control.
Can healthcare advertising break onto the Cannes ad festival main stage?
12 July 2016
Rumblings from healthcare agency executives and marketers about the separation of the Lions Health Festival from the full Cannes Lions International Festival of Creativity were reported inAdvertising Age's final analysis of the event. It noted the "grousing by agency, client and media executives alike" and named WebMD CEO David Schlanger as one of the executives who "believes it's time to more fully integrate health into the main show."
Business as usual for now, but post-Brexit funding, R&D worries remain at forefront
11 July 2016
One week on, and researchers in the U.K. still reeling from the Brexit vote have been told by the science minister Jo Johnson to carry on as before. In legal terms, nothing has changed. "We remain an EU member during the two-year negotiation period, with all rights and obligations that derive from this," Johnson said in a speech given at the headquarters of research charity the Wellcome Trust, to an audience including university vice chancellors, representatives of research funding bodies and practicing scientists.
Where should the EMA move to? That’s not up to us, regulator says
11 July 2016
Confidentially, EMA head Guido Rasi has said that a move from the U.K. to leave the EU was “a nightmare with immediate consequences,” although publicly the regulator has been keen to dampen concerns from behind a wall of silence.
Transparency is the goal as Europe goes live on payment disclosure
11 July 2016
Websites publishing details of payments from pharma companies to health care professionals have gone live as Europe presses the button on its version of the U.S. Sunshine Act, and makes information on money paid to individuals available for public scrutiny for the first time.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024